In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-lnduced autoimmune diabetes

Journal of Immunology

Volumn 161, Issue 9, 1998, Pages 5087-5096

  Von Herrath, Matthias G ^a   Coon, Bryan ^a   Lewicki, Hanna ^a   Mazarguil, Honore ^b   Gairin, Jean Edouard ^b   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLELE; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL KILLING; DRUG RECEPTOR BINDING; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; STEM CELL; TARGET CELL; VIRUS INDUCTION; VIRUS INFECTION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; EPITOPES; H-2 ANTIGENS; IMMUNOLOGIC MEMORY; INSULIN; INTERFERON TYPE II; INTERLEUKIN-4; ISLETS OF LANGERHANS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGOPEPTIDES; PROMOTER REGIONS (GENETICS); RATS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSGENES; VIRAL LOAD;

EID: 0032213343     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Unger, R. H., and D. W. Foster. 1985. In Williams Textbook of Endocrinology, 7th Ed. J. D. Wilson and D. W. Foster, eds. W. B. Saunders, Philadelphia, p. 1018.
2. Eisenbarth, G. A. 1986. Type 1 diabetes mellitus: a chronic autoimmune disease. N. Engl. J. Med. 314:1360.
3. Baekkeskov, S., and B. Hansen. 1990. Human diabetes. Curr. Top. Microbiol. Immunol. 164:1.
4. Bach, J.-F. 1995. Organ-specific autoimmunity. Immunol. Today 16:353.
5. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85: 291.
6. von Herrath, M. G., J. Dockter, and M. B. A. Oldstone. 1994. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1:231.
7. Katz, J., C. Benoist, and D. Mathis 1995. T helper cell subsets in IDDM. Science 268:1185.
8. Green, A. 1990. The role of genetic factors in development of IDDM. Curr. Top. Microbiol. Immunol. 164:3.
9. She, J.-X. 1996. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol. Today 17:323.
10. Theophilopoulos, A. 1995. The basis of autoimmunity. Part II. Genetic predisposition. Immunol. Today 16:150.
11. Bach, J.-F. 1994. Insulin dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:516.
12. Ohashi, P., S. Oehen, K. Buerki, H. Pircher, C. Ohashi, B. Odermatt, B. Malissen, R. Zinkernagel, and R. Hengartner. 1991. Ablation of tolerance and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305.
13. Oldstone, M. B. A., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319.
14. Nicholson, L. B., J. M. Greer, R. A. Sobel, M. B. Lees, and V. K. Kuchroo. 1995. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3:397.
15. Aichele, P., K. Brduscha-Riem, S. Oehen, B. Odermatt, R. M. Zinkernagel, H. Hengartner, and H. Pircher. 1997. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 6:519.
16. Celis, E., A. Sette, and H. M. Grey. 1995. Epitope selection and development of peptide based vaccines to treat cancer. Semin. Cancer Biol. 6:329.
17. Elias, D., and I. R. Cohen. 1994. Peptide therapy for diabetes in NOD mice. Lancet 343:704.
18. Aichele, P., D. Kyburz, P. Ohashi, B. Odermatt, R. M. Zinkernagel, H. Hengartner, and H. P. Pircher. 1994. Peptide induced T-cell tolerance to prevent autoimmune diabetes in a tg mouse model. Proc. Natl. Acad. Sci. USA 91:444.
19. Gaur, A., B. Wiers, A. Liu, J. Rothbard, and C. G. Fathman. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258:1491.
20. Kyburz, D., P. Aichele, D. E. Speiser, H. Hengartner, R. M. Zinkernagel, and H. P. Pircher. 1993. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur. J. Immunol. 23:1956.
21. Shastri, N. 1996. Needles in haystacks: identifying specific peptide antigens for T cells. Curr. Opin. Immunol. 8:271.
22. Tisch, R., and H. McDevitt. 1994. Antigen specific immunotherapy: is it a real possibility to combat T-cell medicated autoimmunity? Proc. Natl. Acad. Sci. USA 91:437.
23. Gairin, J. E., and M. B. A. Oldstone. 1992. Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for the control of viral disease. J Virol. 66:6755.
24. b molecules. Virology 234:62.
25. b major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J. Virol. 69:2297.
26. b cytotoxic T lymphocytes. J. Exp. Med. 168:559.
27. Sette, A., J. Alexander, and H. M. Grey. 1995. Interaction of antigenic peptides with MHC and TCR molecules. Clin. Immunol. Immunopathol. 76:S168.
28. Gairin, J. E., and M. B. A. Oldstone. 1993. Virus and cytotoxic T lymphocytes: 1. Crucial role of viral peptide secondary structure in MHC class I interactions. J. Virol. 67:2903.
29. Lehner, P. J., and P. Cresswell. 1996. Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8:59.
30. Parham, P., and T. Ohta. 1996. Population biology of antigen presentation by MHC class I molecules. Science 272:67.
31. Doherty, P., and R. M. Zinkernagel. 1974. Restriction of in vitro T cell mediated cytotoxicity in LCM within a syngeneic or semiallogeneic system. Nature 248: 701-702.
32. b molecules is controlled by dominant negative elements at peptide non-anchor residues. J. Biol. Chem. 271:17829.
33. Falk, H., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
34. b at 2.4 A resolution: implications for antigen-determinant selection. Cell 76:39.
35. Lewicki, H., M. G. von Herrath, C. F. Evans, J. L. Whitton, and M. B. A. Oldstone. 1995. CTL escape viral variants. II. Biologic activity in vivo. Virology 211:443.
36. Lewicki, H. A., A. Tishon, P. Borrow, C. Evans, J. E. Gairin, K. M. Hahn, D. A. Jewell I. A. Wilson, and M. B. A. Oldstone. 1995. CTL escape viral variants. I. Generation and molecular characterization. Virology 210:29.
37. Yanagi, Y., A. Tishon, H. Lewicki, B. A. Cubitt, and M. B. A. Oldstone. 1992. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule. J. Virol. 66:2527.
38. Thomson, G., W. P. Robinson, S. Joe, M. J. MacDonald, J. L. Gottschall, J. Barbosa, S. S. Rich, J. Betrams, M. P. Baur, J. Partanen, et al. 1988. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 43:799.
39. Vaysburd, M., C. Lock, and H. McDevitt. 1995. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by immunogeneic but not tolerated peptides. J. Exp. Med. 182:897.
40. Yokoyama, M., J. Zhang, and J. L. Whitton. 1995. DNA Immunization confers protection against lethal LCMV infection. J. Virol. 69:2684.
41. von Herrath, M. G., S. Guerder, H. Lewicki, R. Flavell, and M. B. A. Oldstone. 1995. Coexpression of B7.1 and viral (self) transgenes in pancreatic β-cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3:727.
42. von Herrath, M. G., S. Efrat, M. B. A. Oldstone, and M. S. Horwitz. 1996. Focal expression of adenoviral E3 transgenes in β-cells prevents destruction by CTL and autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94:9808.
43. Riviere, Y., and M. B. A. Oldstone. 1986. Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis. J. Virol. 59:363.
44. Klavinskis, L., J. L. Whitton, E. Joly, and M. B. A. Oldstone. 1990. Vaccination and protection from a lethal viral infection: identification, incorporation and use of a CTL glycoprotein epitope. Virology 178:393.
45. Oldstone, M. B. A., H. Lewicki, P. Borrow, D. Hudrisier, and J. E. Gairin. 1995. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection. J. Virol. 69:7423.
46. von Herrath, M. G., T. Dyrberg, and M. B. A. Oldstone. 1996. Oral insulin treatment prevents virus-induced IDDM. J. Clin. Invest. 98:1324.
47. Charlton, B., and K. J. Lafferty 1995. The Th1/Th2 balance in autoimmunity. Curr. Opin. Immunol. 7:793.
48. Chen, Y.-Z., S. Matsushita, and Y. Nishimura. 1996. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide. J. Immunol. 157:3783.
49. Schountz, T., J. P. Kasselman, F. A. Martinson, L. Brown, and J. S. Murray. 1996. MHC genotype controls the capacity of ligand density Io switch T helper (Th)-1/Th-2 priming in vivo. J. Immunol. 157:3893.
50. Rabinowitz, J. D., C. Beeson, C. Wulfing, K. Tate, P. M. Allen, M. M. Davis, and H. M. McConnell. 1996. Altered T cell receptor ligand trigger a subset of easily T cell signals. Immunity 5:125.
51. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T-lymphocyte activation. Cell 76:287.
52. Steinman, L. 1996. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc. Natl. Acad. Sci. USA 93:2253.
53. Morgan, D. J., R. Liblau, B. Scott, S. Fleck, H. O. McDevitt, N. Sarvetnick, D. Lo, and L. Sherman. 1996. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157:978.
54. Ahmed, R. 1996. Tickling memory T cells. Science 272:1904.
55. Ashton-Richardt, P. A., A. Bandeira, J. Delaney, L. Van Kaer, H. P. Pircher, R. M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T-cell selection in the thymus. Cell 76:651.